HRTX · Insider Trading
Heron Therapeutics, Inc.
Every open-market purchase and sale reported by HRTX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-03 | Mark Earl Hensley | Chief Operating Officer | MIXED | +8,421 | −$938 |
| 2026-11-03 | Ira Duarte | EVP, Chief Financial Officer | MIXED | +18,053 | −$2.01K |
| 2026-11-03 | William P Forbes | EVP, Chief Development Officer | MIXED | +16,789 | −$1.87K |
| 2026-11-03 | Craig A Collard | Chief Executive Officer | MIXED | +64,157 | −$5.78K |
| 2026-10-21 | Craig A Collard | Chief Executive Officer | MIXED | +10,437 | −$1.21K |
| 2026-10-21 | William P Forbes | EVP, Chief Development Officer | MIXED | +2,772 | −$397 |
| 2026-10-21 | Ira Duarte | EVP, Chief Financial Officer | MIXED | +2,772 | −$397 |
| 2026-08-10 | Mark Earl Hensley | Chief Operating Officer | MIXED | +22,362 | −$4.44K |
| 2026-08-03 | Mark Earl Hensley | Chief Operating Officer | M | +11,769 | — |
| 2026-08-03 | Ira Duarte | EVP, Chief Financial Officer | MIXED | +18,053 | −$3.59K |
| 2026-08-03 | William P Forbes | EVP, Chief Development Officer | MIXED | +16,789 | −$3.34K |
| 2026-08-03 | Craig A Collard | Chief Executive Officer | M | +84,810 | — |
| 2026-07-20 | Craig A Collard | Chief Executive Officer | M | +13,797 | — |
| 2026-07-20 | William P Forbes | EVP, Chief Development Officer | MIXED | +2,773 | −$517 |
| 2026-07-20 | Ira Duarte | EVP, Chief Financial Officer | MIXED | +2,773 | −$517 |
| 2026-06-17 | Ira Duarte | EVP, Chief Financial Officer | MIXED | +8,945 | −$1.35K |
| 2026-06-08 | William P Forbes | EVP, Chief Development Officer | M | +12,500 | — |
| 2026-05-07 | Mark Earl Hensley | Chief Operating Officer | M | +125,000 | — |
| 2026-05-04 | Ira Duarte | EVP, Chief Financial Officer | M | +25,229 | — |
| 2026-05-04 | Craig A Collard | Chief Executive Officer | M | +84,810 | — |
| 2026-05-04 | William P Forbes | EVP, Chief Development Officer | M | +23,464 | — |
| 2026-05-04 | Mark Earl Hensley | Chief Operating Officer | M | +11,770 | — |
| 2026-04-21 | Craig A Collard | Chief Executive Officer | M | +13,797 | — |
| 2026-04-21 | William P Forbes | EVP, Chief Development Officer | M | +3,874 | — |
| 2026-04-21 | Ira Duarte | EVP, Chief Financial Officer | M | +3,874 | — |
| 2026-04-06 | Craig A Collard | Chief Executive Officer | M | +62,500 | — |
| 2026-02-03 | Thomas Cusack | Director | A | +53,960 | — |
| 2026-02-03 | Sharmila Dissanaike | Director | A | +53,960 | — |
| 2026-02-03 | Waage Christian | Director | A | +53,960 | — |
| 2026-02-03 | Michael Kaseta | Director | A | +53,960 | — |
| 2026-02-03 | Craig A Collard | Chief Executive Officer | M | +34,789 | — |
| 2026-02-03 | Ira Duarte | EVP, Chief Financial Officer | A | +433,123 deriv. | — |
| 2026-02-03 | Craig A Collard | Chief Executive Officer | A | +1,600,673 deriv. | — |
| 2026-02-03 | Ira Duarte | EVP, Chief Financial Officer | M | +11,695 | — |
| 2026-02-03 | William P Forbes | EVP, Chief Development Officer | M | +11,695 | — |
| 2026-02-03 | Craig A Johnson | Director | A | +53,960 | — |
| 2026-02-03 | Adam Morgan | Director | A | +53,960 | — |
| 2026-02-03 | William P Forbes | EVP, Chief Development Officer | A | +376,629 deriv. | — |
| 2026-02-03 | Mark Earl Hensley | Chief Operating Officer | A | +376,629 deriv. | — |
| 2026-01-20 | William P Forbes | EVP, Chief Development Officer | M | +3,875 | — |
| 2026-01-20 | Ira Duarte | EVP, Chief Financial Officer | M | +3,875 | — |
| 2026-01-20 | Craig A Collard | Chief Executive Officer | M | +13,797 | — |
| 2025-11-12 | Thomas Cusack | Director | A | +37,879 | — |
| 2025-11-04 | Craig A Collard | Chief Executive Officer | M | +34,789 | — |
| 2025-11-04 | William P Forbes | EVP, Chief Development Officer | M | +11,694 | — |
| 2025-11-04 | Ira Duarte | EVP, Chief Financial Officer | M | +11,694 | — |
| 2025-10-21 | Craig A Collard | Chief Executive Officer | M | +13,797 | — |
| 2025-10-21 | Ira Duarte | EVP, Chief Financial Officer | M | +3,874 | — |
| 2025-10-21 | William P Forbes | EVP, Chief Development Officer | M | +3,874 | — |
| 2025-10-17 | Rubric Capital Management LP | 10%+ Owner | C | +946,100 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Rubric Capital Management LP | 10%+ Owner | 30,046,828 | $11.14M |
| Adam Morgan | Director | 8,877,027 | $3.29M |
| Craig A Collard | Chief Executive Officer | 931,086 | $345.06K |
| Ira Duarte | EVP, Chief Financial Officer | 306,051 | $113.42K |
| William P Forbes | EVP, Chief Development Officer | 252,366 | $93.53K |
| Mark Earl Hensley | Chief Operating Officer | 179,322 | $66.46K |
| Susan Rodriguez | Director | 87,180 | $32.31K |
| Craig A Johnson | Director | 53,960 | $20.00K |
| Waage Christian | Director | 53,960 | $20.00K |
| Michael Kaseta | Director | 53,960 | $20.00K |
| Sharmila Dissanaike | Director | 53,960 | $20.00K |
| Thomas Cusack | Director | 53,960 | $20.00K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the HRTX quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.